Results     10-May-22
Announcements
Ajanta Pharma consolidated net profit declines 5.05% in the March 2022 quarter
Sales rise 14.99% to Rs 870.29 crore
Net profit of Ajanta Pharma declined 5.05% to Rs 151.21 crore in the quarter ended March 2022 as against Rs 159.26 crore during the previous quarter ended March 2021. Sales rose 14.99% to Rs 870.29 crore in the quarter ended March 2022 as against Rs 756.84 crore during the previous quarter ended March 2021.

For the full year,net profit rose 8.99% to Rs 712.68 crore in the year ended March 2022 as against Rs 653.87 crore during the previous year ended March 2021. Sales rose 15.62% to Rs 3340.99 crore in the year ended March 2022 as against Rs 2889.69 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales870.29756.84 15 3340.992889.69 16
OPM %23.7534.28 -27.8234.56 -
PBDT228.83259.38 -12 1034.781016.27 2
PBT197.67228.78 -14 909.48900.18 1
NP151.21159.26 -5 712.68653.87 9

Previous News
  Indices pare all early gains; metal shares rally for 2nd day
 ( Market Commentary - Mid-Session 03-May-24   10:36 )
  Sensex tanks 909 pts; European mkt opens higher
 ( Market Commentary - Mid-Session 03-May-24   13:42 )
  Volumes jump at Ajanta Pharma Ltd counter
 ( Hot Pursuit - 03-May-24   11:00 )
  Ajanta Pharma consolidated net profit declines 5.93% in the March 2019 quarter
 ( Results - Announcements 02-May-19   09:07 )
  Ajanta Pharma standalone net profit declines 47.30% in the March 2019 quarter
 ( Results - Announcements 02-May-19   09:44 )
  Ajanta Pharma to announce Quarterly Result
 ( Corporate News - 27-Apr-23   14:34 )
  Ajanta Pharma consolidated net profit declines 54.63% in the December 2018 quarter
 ( Results - Announcements 31-Jan-19   08:57 )
  Ajanta Pharma gains after launching anti-dementia drug in US
 ( Hot Pursuit - 14-Jun-16   13:30 )
  Ajanta Pharma receives final approval for Aripiprazole Tablets
 ( Corporate News - 14-Sep-16   11:30 )
  Ajanta Pharma net profit rises 66.19% in the June 2013 quarter
 ( Results - Announcements 29-Jul-13   17:43 )
  Ajanta Pharma's Dahej unit undergoes USFDA audit
 ( Corporate News - 12-Sep-22   12:00 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top